Skip to main content
logo
Charming Medical Limited (MCTA)
NASDAQ: MCTA · Real-Time Price · USD
29.11
-0.25 (-0.83%)
Nov 11, 2025, 4:00 PM EDT - Market closed

Charming Medical Cash Flow Statement

Millions USD. Fiscal year is Apr - Mar.

Operating Activities

Fiscal Year
FY 2026FY 2025FY 2024FY 2023
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23
Net Income
-0.021.20.78-0.31
Depreciation & Amortization
0.220.260.390.21
Loss (Gain) From Sale of Assets
-0.01---
Loss (Gain) From Sale of Investments
-0.02-0--
Other Operating Activities
0.040.130.070.03
Change in Accounts Receivable
0.19-0.04-0.16-0.15
Change in Inventory
000.04-0.06
Change in Accounts Payable
0.17-0.20.210.18
Change in Unearned Revenue
-0.42-1.06-1.112.73
Change in Income Taxes
0.090.10.12-
Change in Other Net Operating Assets
-1.450.04-0.04-0.11
Operating Cash Flow
-1.220.430.32.43
Operating Cash Flow Growth
-44.16%-87.86%-

Investing Activities

Fiscal Year
FY 2026FY 2025FY 2024FY 2023
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23
Capital Expenditures
-0.34-0.29-0.21-0.61
Sale of Property, Plant & Equipment
0.03---
Investment in Securities
0.13-1.94--
Investing Cash Flow
-0.18-2.23-0.21-0.61

Financing Activities

Fiscal Year
FY 2026FY 2025FY 2024FY 2023
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23
Short-Term Debt Issued
0.671.21.54-
Long-Term Debt Issued
-0.210.04-
Total Debt Issued
0.671.411.58-
Short-Term Debt Repaid
-1-0.31-1.44-0.18
Long-Term Debt Repaid
-0.11-0.03-0.01-
Total Debt Repaid
-1.12-0.34-1.45-0.18
Net Debt Issued (Repaid)
-0.451.070.13-0.18
Issuance of Common Stock
6.91---
Other Financing Activities
-1.18-0.55-0.03-1.25
Financing Cash Flow
5.290.520.1-1.43

Net Cash Flow

Fiscal Year
FY 2026FY 2025FY 2024FY 2023
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23
Foreign Exchange Rate Adjustments
-0.01-0-0.010.01
Net Cash Flow
3.88-1.290.170.4

Free Cash Flow

Fiscal Year
FY 2026FY 2025FY 2024FY 2023
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23
Free Cash Flow
-1.560.140.081.83
Free Cash Flow Growth
-63.10%-95.36%-
Free Cash Flow Margin
-32.35%2.22%1.41%51.76%
Free Cash Flow Per Share
-0.100.010.010.12
Levered Free Cash Flow
-0.510.891.04-
Unlevered Free Cash Flow
-0.50.91.06-

Additional Metrics

Fiscal Year
FY 2026FY 2025FY 2024FY 2023
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23
Cash Interest Paid
0.020.020.030.02
Change in Working Capital
-1.42-1.16-0.942.5
SEC Filings: 10-K · 10-Q